Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex Acquires Labindia's Mass Spec Services Business to Expand Footprint in India

Premium

This story originally ran on Nov. 17.

By Adam Bonislawski

AB Sciex said this week it has acquired Indian life sciences services provider Labindia's mass spectrometry division.

The deal, which stems from an ongoing partnership between the two companies, will expand AB Sciex's footprint in the fast-growing Indian market, "allowing the company to engage in a new level of dialogue with Indian scientists," Umesh Pawa, managing director of AB Sciex India, said in a statement.

Labindia's offerings include a variety of proteomics services, including LC-MS and biomarker discovery work. According to Pawa, demand for proteomics research is growing in India, with much of it focused on biomarker discovery and plant proteomics.

"Protein biomarker discovery is in full swing in India," he told ProteoMonitor, noting that tropical infectious diseases and oncology were particular areas of focus.

"There's also significant [work] going on in plant proteomics, because a large portion of the Indian economy is dependent on agriculture," Pawa said.

Most of India's proteomics research is government funded, he said, with support coming from bodies including the Department of Science and Technology, the Department of Biotechnology, and the National Institute of Plant Genome Research.

"The majority of [India's] proteomics market revolves around [such] research institutes, followed by academia," he said.

While private firms including drug companies have begun to incorporate proteomics, they still represent a small portion of the market, Pawa said.

"Pharma in India is still a little ways from [widespread use of] proteomics applications," he said. "Almost all pharma companies have some amount of proteomics work going on, but I wouldn't compare it to the levels in the United States or Europe."

Financial terms of the agreement were not released.


Have topics you'd like to see covered in ProteoMonitor? Contact the editor at abonislawski [at] genomeweb [.] com.
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.